ML-B01
ML-B01 is a potent, orally bioavailable dual inhibitor of Akt (IC50=2 nM) and PKA (IC50=136 nM) . Its demonstrated blood-brain barrier permeability in mice supports its utility for in vivo research, particularly in studying central nervous system cancers and signaling pathways.
Product Specifications
Field of Research
Signal Transduction
Molecular Formula
C24H31Cl2N5O
Molecular Weight
476.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6250462-01 0.1 mL
CD1a (CD1, CD1A Antigen, Cortical Thymocyte Antigen CD1A, Epidermal Dendritic Cell Marker CD1a, FCB 6, HTA1, T Cell Surface Antigen Leu 6, Cell Surface Antigen T6, T Cell Surface Antigen T6/Leu 6, T Cell Surface Glycoprotein CD1A, T6, Thymocyte Antigen CD
Sign In for Pricing
View Details MBS6250462-02 5x 0.1 mL
CD1a (CD1, CD1A Antigen, Cortical Thymocyte Antigen CD1A, Epidermal Dendritic Cell Marker CD1a, FCB 6, HTA1, T Cell Surface Antigen Leu 6, Cell Surface Antigen T6, T Cell Surface Antigen T6/Leu 6, T Cell Surface Glycoprotein CD1A, T6, Thymocyte Antigen CD
Sign In for Pricing
View Details